Table of Contents
Chapter 1 Report Scope and Objectives
1.1 Market Segmentation & Scope
1.2 Regional Scope
1.2.1 Estimates And Forecast Timeline
1.3 Objectives
1.3.1 Objective – 1
1.3.2 Objective – 2
1.3.3 Objective – 3
Chapter 2 Methodology
2.1 Research Methodology
2.2 Information Procurement
2.2.1 Purchased Database
2.2.2 Gvr’s Internal Database
2.2.3 Secondary Sources
2.2.4 Primary Research
2.3 Information Or Data Analysis
2.3.1 Data Analysis Models
2.4 Market Formulation & Validation
2.5 Model Details
2.5.1 Commodity Flow Analysis (Model 1)
2.5.2 Volume Price Analysis (Model 2)
2.6 List Of Secondary Sources
Chapter 3 Executive Summary
3.1 Market Outlook
3.2 Segment Outlook
3.2.1 Product
3.2.2 Indication
3.2.3 Distribution Channel
3.2.4 End Use
3.2.5 Region
3.3 Competitive Insights
3.4 Digital Respiratory Devices Market Outlook, 2021
Chapter 4 Market Variables, Trends & Scope
4.1 Market Lineage Outlook
4.1.1 Parent Market Outlook
4.1.2 Ancillary Market Outlook
4.2 Digital Respiratory Devices Market Dynamics
4.2.1 Market Driver Analysis
4.2.2 Market Restraint Analysis
4.3 Digital Respiratory Devices Market: Business Environment Analysis Tools
4.3.1 Porter’s Five Forces Analysis
4.3.1.1 Threat of new entrants
4.3.1.2 Bargaining power of suppliers
4.3.1.3 Bargaining power of buyers
4.3.1.4 Competitive rivalry
4.3.1.5 Threat of substitutes
4.3.2 PESTEL Analysis
4.3.2.1 Political & legal
4.3.2.2 Economic & social
4.3.2.3 Technological
4.3.2.4 Environmental
4.4 Penetration & Growth Prospect Mapping
4.5 Technology Trend Analysis
4.6 Regulatory Framework
4.7 Impact of COVID-19 on Digital Respiratory Devices Market
Chapter 5 Digital Respiratory Devices Market: Product Analysis
5.1 Digital Respiratory Devices Product Market Share Analysis, 2021 & 2030
5.2 Digital Respiratory Devices Product Market: Segment Dashboard
5.3 Market Size & Forecasts and Trend Analyses, 2017 to 2030 for the Product Segment
5.3.1 Sensors And Apps
5.3.1.1 sensors And Apps Market, 2017 – 2030 (USD Million)
5.3.2 Smart Inhalers And Nebulizers
5.3.2.1 Smart inhalers and nebulizers market, 2017 – 2030 (USD Million)
Chapter 6 Digital Respiratory Devices Market: Indication Analysis
6.1 Digital Respiratory Devices Indication Market Share Analysis, 2021 & 2030
6.2 Digital Respiratory Devices Indication Market: Segment Dashboard
6.3 Market Size & Forecasts and Trend Analyses, 2017 to 2030 for the Indication Segment
6.3.1 Asthma
6.3.1.1 Asthma market, 2017- 2030 (USD Million)
6.3.2 COPD
6.3.2.1 COPD market, 2017 – 2030 (USD Million)
6.3.3 Others
6.3.3.1 Others market, 2017- 2030 (USD Million)
Chapter 7 Digital Respiratory Devices Market: Distribution Channel Analysis
7.1 Digital Respiratory Devices Distribution Channel Market Share Analysis, 2021 & 2030
7.2 Digital Respiratory Devices Distribution Channel Market: Segment Dashboard
7.3 Market Size & Forecasts And Trend Analyses, 2017 To 2030 For The Distribution Channel
7.3.1 Hospitals Pharmacies
7.3.1.1 Hospitals Pharmacies Market, 2017- 2030 (USD Million)
7.3.2 Retail Pharmacies
7.3.2.1 Retail Pharmacies Market, 2017 – 2030 (USD Million)
7.3.3 Online Pharmacies
7.3.3.1 Online pharmacies market, 2017- 2030 (USD Million)
Chapter 8 Digital Respiratory Devices Type Market: END-USE Analysis
8.1 Digital Respiratory Devices Type Market Share Analysis, 2021 & 2030
8.2 Digital Respiratory Devices End-Use Market: Segment Dashboard
8.3 Market Size & Forecasts and Trend Analyses, 2017 to 2030 for the End Use Segment
8.3.1 Hospitals
8.3.1.1 Hospitals Market, 2017- 2030 (USD Million)
8.3.2 Homcare Settings
8.3.2.1 Homecare Settings Market, 2017- 2030 (USD Million)
8.3.3 Other Settings
8.3.3.1 Other settings market, 2017- 2030 (USD Million)
Chapter 9 Digital Respiratory Devices Market: Regional Analysis
9.1 Digital Respiratory Devices Regional Market Share Analysis, 2021 & 2030
9.2 Regional Market Snapshot
9.3 North America
9.3.1 North America Digital Respiratory Devices Market, 2017 – 2030 (USD Million)
9.3.2 U.S.
9.3.2.1 U.S. Digital Respiratory Devices Market, 2017 – 2030 (USD Million)
9.3.3 Canada
9.3.3.1 Canada digital respiratory devices market, 2017 – 2030 (USD Million)
9.4 Europe
9.4.1 Europe Digital Respiratory Devices Market, 2017 – 2030 (USD Million)
9.4.2 U.K.
9.4.2.1 U.K. Digital Respiratory Devices Market, 2017 – 2030 (USD Million)
9.4.3 Germany
9.4.3.1 Germany Digital Respiratory Devices Market, 2017 – 2030 (USD Million)
9.4.4 France
9.4.4.1 France digital respiratory devices market, 2017 – 2030 (USD Million)
9.4.5 Italy
9.4.5.1 Italy digital respiratory devices market, 2017 – 2030 (USD Million)
9.4.6 Spain
9.4.6.1 Spain Digital Respiratory Devices Market, 2017 – 2030 (USD Million)
9.5 Asia Pacific
9.5.1 Asia Pacific Digital Respiratory Devices Market, 2017 – 2030 (USD Million)
9.5.2 Japan
9.5.2.1 Japan Digital Respiratory Devices Market, 2017 – 2030 (USD Million)
9.5.3 China
9.5.3.1 China Digital Respiratory Devices Market, 2017 – 2030 (USD Million)
9.5.4 India
9.5.4.1 India digital respiratory devices market, 2017 – 2030 (USD Million)
9.6 Latin America
9.6.1 Latin America Digital Respiratory Devices Market, 2017 – 2030 (USD Million)
9.6.2 Brazil
9.6.2.1 Brazil Digital Respiratory Devices Market, 2017 – 2030 (USD Million)
9.6.3 Mexico
9.6.3.1 Mexico Digital Respiratory Devices Market, 2017 – 2030 (USD Million)
9.7 Middle East And Africa (Mea)
9.7.1 Mea Digital Respiratory Devices Market, 2017 – 2030 (USD Million)
9.7.2 South Africa
9.7.2.1 South Africa digital respiratory devices market, 2017 – 2030 (USD Million)
Chapter 10 Competitive Analysis
10.1 Recent Developments & Impact Analysis, By Key Market Participants
10.2 Company Profiles
10.2.1 COHERO HEALTH, INC.
10.2.1.1 Company overview
10.2.1.2 Financial performance
10.2.1.3 Product benchmarking
10.2.1.4 Strategic initiatives
10.2.2 COGNITA LABS
10.2.2.1 Company overview
10.2.2.2 Financial performance
10.2.2.3 Product benchmarking
10.2.2.4 Strategic initiatives
10.2.3 ADHERIUM LIMITED
10.2.3.1 Company overview
10.2.3.2 Financial performance
10.2.3.3 Product benchmarking
10.2.3.4 Strategic initiatives
10.2.4 AMIKO DIGITAL HEALTH LIMITED
10.2.4.1 Company overview
10.2.4.2 Financial performance
10.2.4.3 Product benchmarking
10.2.4.4 Strategic initiatives
10.2.5 TEVA PHARMACEUTICALS INDUSTRIES LTD.
10.2.5.1 Company overview
10.2.5.2 Financial performance
10.2.5.3 Product benchmarking
10.2.5.4 Strategic initiatives
10.2.6 PROPELLER HEALTH
10.2.6.1 Company overview
10.2.6.2 Financial performance
10.2.6.3 Product benchmarking
10.2.6.4 Strategic initiatives
10.2.7 NOVARTIS AG
10.2.7.1 Company overview
10.2.7.2 Financial performance
10.2.7.3 Product benchmarking
10.2.7.4 Strategic initiatives
10.2.8 PNEUMA RESPIRATORY, INC.
10.2.8.1 Company overview
10.2.8.2 Financial performance
10.2.8.3 Product benchmarking
10.2.8.4 Strategic initiatives
10.2.9 3M HEALTH CARE LIMITED
10.2.9.1 Company overview
10.2.9.2 Financial performance
10.2.9.3 Product benchmarking
10.2.9.4 Strategic initiatives
10.2.10 FINDAIR SP. Z O.O.
10.2.10.1 Company overview
10.2.10.2 Financial performance
10.2.10.3 Product benchmarking
10.2.10.4 Strategic initiatives
10.2.11 AIREHEALTH, INC.
10.2.11.1 Company overview
10.2.11.2 Financial performance
10.2.11.3 Product benchmarking
10.2.11.4 Strategic initiatives